<html>
<head>PUBMED IDs for CSNK2A1</head>
<body bgcolor='#C5F0F2'><h1>CSNK2A1</h1><a href='https://pubmed.ncbi.nlm.nih.gov/8188256/'>The human gene (CSNK2A1) coding for the casein kinase II subunit alpha is located on chromosome 20 and contains tandemly arranged Alu repeats.</a> January 15  1994<br><a href='https://pubmed.ncbi.nlm.nih.gov/9172313/'>Assignment of the casein kinase II gene family to cattle chromosomes.</a> April 1  1997<br><a href='https://pubmed.ncbi.nlm.nih.gov/9503018/'>Genomic organization and promoter identification of the human protein kinase CK2 catalytic subunit alpha (CSNK2A1).</a> March 21  1998<br><a href='https://pubmed.ncbi.nlm.nih.gov/10328623/'>Cytogenetic alignment of the bovine chromosome 13 genome map by fluorescence in-situ hybridization of human chromosome 10 and 20 comparative markers.</a> May 18  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/19210549/'>Visual screening and analysis for kinase-regulated membrane trafficking pathways that are involved in extensive beta-amyloid secretion.</a> April 2  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/20610541/'>Genome-wide association study for colorectal cancer identifies risk polymorphisms in German familial cases and implicates MAPK signalling pathways in disease susceptibility.</a> October 1  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20625391/'>Functional polymorphism of the CK2alpha intronless gene plays oncogenic roles in lung cancer.</a> October 29  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/22023465/'>Influences of genetic variation on fetal hemoglobin.</a> September 14  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/26437031/'>Integrated molecular analysis of adult T cell leukemia/lymphoma.</a> March 8  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26637171/'>A Synthetic Lethality Screen Using a Focused siRNA Library to Identify Sensitizers to Dasatinib Therapy for the Treatment of Epithelial Ovarian Cancer.</a> June 28  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26728723/'>WNT-associated gene expression in human mesenchymal stromal cells under hypoxic stress.</a> October 12  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/26876164/'>Molecular characterization of clear cell renal cell carcinoma identifies CSNK2A1, SPP1 and DEFB1 as promising novel prognostic markers.</a> August 23  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27048600/'>De novo mutations in CSNK2A1 are associated with neurodevelopmental abnormalities and dysmorphic features.</a> June 22  2016<br></body></html>
